Results 71 to 80 of about 1,831 (172)

Chemical structures of the endogenous steroids progesterone (Prog) and testosterone, the synthetic MR antagonist spironolactone, and the progestins used in this study

open access: yes, 2016
: Medroxyprogesterone acetate (MPA), nestorone (NES), nomegestrol acetate (NoMAC), norethisterone/norethindrone acetate (NET-A), levonorgestrel (LNG), gestodene (GES) and drospirenone (DRSP).
Meghan S. Perkins (3152736)   +4 more
core   +1 more source

A Comparative Metabolomics Study of the Potential Marker Compounds in Feces from Different Hybrid Offspring of Huainan Pigs

open access: yesAnimals
As a notable native Chinese genetic population, the Huainan pig has an exceptional meat quality but a low percentage of lean meat and subpar genetic performance.
Yufu Li   +8 more
doaj   +1 more source

Development of efficient SPE–TLC method and evaluation of biological interactions of contraceptives with progesterone receptors

open access: yes, 2012
TLC–SPE methodologies were developed to ascertain biological interactions of norethindrone acetate and dydrogesterone contraceptives with plasma progesterone receptor proteins.
Hussain, Iqbal   +7 more
core   +1 more source

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials

open access: yesF&S Reports
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D.   +4 more
doaj   +1 more source

Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109

open access: yes, 2017
Context OBE2109 is a potent, oral gonadotropin-releasing hormone receptor antagonist being developed for the treatment of sex-hormone–dependent diseases in women. Objective
Line Marchand   +4 more
core   +1 more source

Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study

open access: yesScientific Reports
To evaluate if a preoperative medical treatment with the GnRH-antagonist relugolix in combination therapy in a series of patients with abnormal uterine bleeding associated with uterine myomas may correct the anemia before scheduled surgery for myoma ...
Ludovico Muzii   +9 more
doaj   +1 more source

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique ® ) in the treatment of endometriosis symptoms: A prospective open-label comparative study

open access: yes, 2018
Introduction: This patient preference prospective study was designed to compare patients' satisfaction in women with endometriosis treated either by an extended-cycle oral contraception (OC) or by norethindrone acetate (NETA).
F. Barra   +9 more
core   +1 more source

Norethindrone ensures masculinization, normal growth and secondary sexual characteristics in the fighting fish, Betta splendens [PDF]

open access: yes, 2008
To ensure masculinization and normal growth of the obligately air-breathing fighting fish Betta splendens, norethindrone acetate (NE) was administered through discrete immersions for 3 h each on the second, fifth and eighth day post-hatching (dph) at ...
Pandian, T. J., Balasubramani, A.
core   +1 more source

Home - About - Disclaimer - Privacy